Literature DB >> 24900697

Imidazopyrazine Derivatives As Inhibitors of mTOR.

Gerard Rosse1.   

Abstract

Entities:  

Year:  2013        PMID： 24900697      PMCID： PMC4027404          DOI： 10.1021/ml400139e

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  2 in total

Review 1.  mTOR is a key modulator of ageing and age-related disease.

Authors:  Simon C Johnson; Peter S Rabinovitch; Matt Kaeberlein
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

Review 2.  The Mammalian target of rapamycin inhibitors in breast cancer: current evidence and future directions.

Authors:  Paola Malaguti; Sabrina Vari; Francesco Cognetti; Alessandra Fabi
Journal:  Anticancer Res       Date:  2013-01       Impact factor: 2.480
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.